- http://zhejiang.chinadaily.com.cn/shaoxing/usefulinfo.html
-
Shaoxing residents need to take nucleic acid test every week
June 2, 2022
Shaoxing has now stretched the nucleic acid test interval to seven days, starting May 31.
-
Chinese-made Omicron vaccine trials get going
May 5, 2022
China began clinical trials for a vaccine designed specifically against the Omicron variant in Hangzhou, Zhejiang province, on Sunday, making it the first vaccine of its kind to enter human trials in the world against the highly transmissible COVID-19 strain.
-
FAQs about antigen self-testing for COVID-19
March 16, 2022
Who can use a COVID-19 antigen self-test? Where to buy the self-testing kits? Can antigen self-testing be a substitute for nucleic acid testing? Here is some important information about the newly approved COVID-19 antigen self-testing.
-
Self-test kits OK'd for earlier detection
March 16, 2022
China has granted approval to five COVID-19 antigen test kits made by local companies to be used for self-testing as a way to beef up early detection capabilities to cope with the more evasive and transmissible Omicron variant.
-
China widens choices for COVID-19 booster shots
February 21, 2022
China began delivering COVID-19 booster shots over the weekend based on technologies different from those used in initial inoculations in the country, in an effort to reinforce herd immunity against the disease.
-
Shaoxing encourages booster shoots to fight Omicron
January 14, 2022
Nealy 100 million residents in Shaoxing, East China's Zhejiang province, have received booster vaccine injections so far as the new COVID-19 variant Omicron emerged in Northern Chinese city of Tianjin, local healthcare authorities announced on Jan 14.
-
New antibody drug to boost COVID fight
December 24, 2021
Nearly two years after the COVID-19 outbreak, China has granted emergency approval for its first antibody combination therapy for COVID-19 treatment, adding a tool to the world's arsenal against the disease.
-
What we know about the Omicron variant so far
December 1, 2021
Answers to commonly-asked questions about the Omicron variant of COVID-19.